Skip to main content

JPMORGAN CHASE & CO

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 19617 NEW YORK, NY

Position in XENE

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$157,983,846
+$46,125,927 QoQ
Shares Held
2,617,360
+36.1% QoQ
Ownership
2.70%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 314 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in XENE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. XENE ranks #11 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XENE

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $157,983,846 2,617,360
2026-03-31 $111,857,919 1,923,610
2025-12-31 $66,962,511 1,494,032
2025-09-30 $56,171,171 1,399,033
2025-06-30 $39,330,981 1,256,581
2025-03-31 $45,547,543 1,357,602
2024-12-31 $53,190,281 1,356,895
2024-09-30 $38,455,943 976,783
2024-06-30 $2,793,786 71,654
2024-03-31 $1,576,531 36,621
2023-12-31 $2,431,414 52,788
2023-09-30 $1,718,144 50,297
2023-06-30 $3,049,853 79,217
2023-03-31 $1,173,445 32,787
2022-12-31 $82,289 2,087
2022-09-30 $154,182 4,271
2022-06-30 $74,406 2,446
2022-03-31 $194,761 6,371
2021-12-31 $149,170 4,775
2021-09-30 $46,053 3,014
2021-06-30 $37,965 2,039
2021-03-31 $116,438 6,505
2020-12-31 $892 58
2020-06-30 $1,208,504 96,372
2020-03-31 $568,349 50,119